1. Home
  2. CPAY vs DXCM Comparison

CPAY vs DXCM Comparison

Compare CPAY & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corpay Inc.

CPAY

Corpay Inc.

HOLD

Current Price

$290.50

Market Cap

22.5B

Sector

Technology

ML Signal

HOLD

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$61.81

Market Cap

26.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPAY
DXCM
Founded
1986
1999
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.5B
26.5B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
CPAY
DXCM
Price
$290.50
$61.81
Analyst Decision
Buy
Strong Buy
Analyst Count
11
21
Target Price
$378.91
$85.33
AVG Volume (30 Days)
612.6K
3.4M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
7.59
47.18
EPS
15.03
2.09
Revenue
$4,528,403,000.00
N/A
Revenue This Year
$18.83
$14.48
Revenue Next Year
$10.56
$12.39
P/E Ratio
$18.94
$29.76
Revenue Growth
13.93
N/A
52 Week Low
$252.84
$54.11
52 Week High
$361.99
$89.07

Technical Indicators

Market Signals
Indicator
CPAY
DXCM
Relative Strength Index (RSI) 39.45 28.92
Support Level $276.91 $54.11
Resistance Level $294.56 $69.18
Average True Range (ATR) 10.80 1.98
MACD -1.49 -0.44
Stochastic Oscillator 19.69 4.34

Price Performance

Historical Comparison
CPAY
DXCM

About CPAY Corpay Inc.

Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. The company offers payment and spend management solutions, including accounts payable automation, cross-border payments, commercial card programs, vehicle payment solutions, and lodging payment services. Its reportable segments are: Corporate Payments, Vehicle Payments, Lodging Payments and Other. The majority of the company's revenue is derived from the Vehicle Payments segment, which helps customers to pay for vehicle related expenses. Geographically, it derives the maximum revenue from the United States and the rest from Brazil, the United Kingdom and other countries.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: